» Articles » PMID: 33110607

Effects of Maximal Strength Training on Bone Mineral Density in People Living with HIV and Receiving Anti-retroviral Therapy: a Pilot Study

Overview
Publisher Biomed Central
Specialty Orthopedics
Date 2020 Oct 28
PMID 33110607
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Anti-retroviral therapy (ART) is associated with low bone mineral density (BMD) among people living with HIV (PLWHIV). Although physical activity is recommended for improving bone health in patients with reduced BMD, data on effects of strength exercises on low BMD among PLWHIV is scarce. This study therefore aimed to determine the effects of a 12 weeks maximal strength training (MST) on BMD among PLWHIV in Blantyre, Malawi.

Methods: Twenty-six PLWHIV with reduced BMD were randomised into a training group (TG,  = 15) and control group (CG,  = 11). The TG underwent 12 weeks of MST consisting of 4 sets of 3 to 5 repetitions at 85-90% of one repetition maximum (1RM) 3 times per week. The CG was advised to maintain their usual lifestyle. Measurements of BMD using dual-energy X-ray absorptiometry, 1RM using a squat machine, heart rate using a heart rate monitor, weight, height and body mass index were obtained before and after the intervention in the TG and CG. Descriptive statistics and student's t - tests were used to analyse data.

Results: The study was conducted for 12 weeks. Data of 24 participants [14 (TG) and 10 (CG)] were analysed. At base line, there were no significant differences in age ( = 0.34), height ( = 0.91), weight ( = 0.43) and body mass index ( = 0.34) between participants in the TG and the CG. After the intervention, there were significant improvements in lumbar BMD ( < 0.001) and resting heart rate ( = 0.03) in the TG compared to the CG. There were significant improvements in muscle strength (1 RM) in both the TG ( < 0.001) and the CG ( = 0.01).

Conclusions: MST improves lumbar BMD and strength in PLWHIV receiving ART in Blantyre, Malawi. MST with a shorter exercise duration of 12 weeks seem to have the potential in treating reduced BMD in PLWHIV.

Trial Registration: PACTR201712002889203. Registered with the Pan African Clinical Trial Registry on 22nd December, 2017 at www. pactr.org.

Citing Articles

Bone Disease in HIV: Need for Early Diagnosis and Prevention.

Schinas G, Schinas I, Ntampanlis G, Polyzou E, Gogos C, Akinosoglou K Life (Basel). 2024; 14(4).

PMID: 38672792 PMC: 11051575. DOI: 10.3390/life14040522.


Correlates of physical activity among people living with and without HIV in rural Uganda.

Mabweazara S, Manne-Goehler J, Bibangambah P, Kim J, Ruth S, Hemphill L Front Reprod Health. 2023; 5:1093298.

PMID: 37547804 PMC: 10398393. DOI: 10.3389/frph.2023.1093298.


Osteoporosis, Rather Than Sarcopenia, Is the Predominant Musculoskeletal Disease in a Rural South African Community Where Human Immunodeficiency Virus Prevalence Is High: A Cross-Sectional Study.

Gregson C, Madanhire T, Rehman A, Ferrand R, Cappola A, Tollman S J Bone Miner Res. 2021; 37(2):244-255.

PMID: 34694025 PMC: 10071443. DOI: 10.1002/jbmr.4464.


Chinese Herbal Medicine Usage Reduces Overall Mortality in HIV-Infected Patients With Osteoporosis or Fractures.

Ho M, Li T, Li J, Chiou J, Chiu M, Chen C Front Pharmacol. 2021; 12:593434.

PMID: 33935696 PMC: 8085888. DOI: 10.3389/fphar.2021.593434.

References
1.
Chitu-Tisu C, Barbu E, Lazar M, Ion D, Badarau I . Low bone mineral density and associated risk factors in HIV-infected patients. Germs. 2016; 6(2):50-9. PMC: 4956161. DOI: 10.11599/germs.2016.1089. View

2.
Ryan A, Ivey F, Hurlbut D, Martel G, Lemmer J, Sorkin J . Regional bone mineral density after resistive training in young and older men and women. Scand J Med Sci Sports. 2004; 14(1):16-23. DOI: 10.1111/j.1600-0838.2003.00328.x. View

3.
Santos W, Santos W, Paes P, Ferreira-Silva I, Santos A, Vercese N . Impact of Strength Training on Bone Mineral Density in Patients Infected With HIV Exhibiting Lipodystrophy. J Strength Cond Res. 2015; 29(12):3466-71. DOI: 10.1519/JSC.0000000000001001. View

4.
Escota G, Mondy K, Bush T, Conley L, Brooks J, Onen N . High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years Among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2015; 32(1):59-67. DOI: 10.1089/aid.2015.0158. View

5.
Chisati E, Constantinou D, Lampiao F . Management of Reduced Bone Mineral Density in HIV: Pharmacological Challenges and the Role of Exercise. Front Physiol. 2018; 9:1074. PMC: 6090029. DOI: 10.3389/fphys.2018.01074. View